Insider Transaction Report for Jonathan Poole

Jonathan Poole, a director at ACADIA PHARMACEUTICALS INC, reported several transactions on May 29, 2026. He acquired 2,010 shares of Common Stock and was granted 16,004 Director Stock Options. Additionally, he acquired 9,311 Restricted Stock Units. Some of these units vested immediately, while others have vesting schedules tied to future events such as continued service, a change in control, or specific dates. The options have an exercise price of $21.66 and vest quarterly over one year. The transactions were reported on Form 4.